Literature DB >> 27487738

Genetic Analysis of Mismatch Repair Genes Alterations in Extramammary Paget Disease.

Zhihua Kang1, Feng Xu, Yingfeng Zhu, Pan Fu, Qiao-An Zhang, Tingting Hu, Xiangyu Li, Qunfeng Zhang, Zhiyuan Wu, Xinju Zhang, Hua Wang, Jinhua Xu, Zujun Fang, Ming Guan.   

Abstract

Extramammary Paget disease (EMPD) is a rare cutaneous malignant neoplasm. The familial occurrence of EMPD and the high risk of concomitant secondary tumors in EMPD patients have gained much attention. These findings highlight the importance of genetic alterations in the tumorigenesis of this skin cancer. Genetic tests and functional analysis of mismatch repair (MMR) genes were performed in EMPD. The results showed that 8 of 20 cases with germline MMR genes mutations and 5 of them exhibited microsatellite instability (MSI). Immunohistochemical staining showed that the tumor tissues from 20 patients had the normal expression of MLH1 but 5 cases had the reduced expression of MSH2. There is a nearly significant correlation between MSI and germline mutations. In 172 cases, rates of germline and somatic mutations were 34.3% and 13.4%, respectively. The mutations of MLH1 V384D (15.7%), R217C (4.1%), and I219V (5.2%) were common in this cancer. In addition, the yeast 2-hybrid and immunoprecipitation assays exhibited reduced interaction between MLH1 and PMS2 in MLH1 V384D and R217C but not I219V. Moreover, MLH1 V384D and R217C had impaired MMR activity compared with the wild-type and I219V mutation by an in vitro MMR assay. The germline mutations in MMR genes are involved in the pathogenesis of EMPD and partially explain the genetic abnormalities for this disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27487738     DOI: 10.1097/PAS.0000000000000709

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

Review 1.  Surgical Treatment for Extramammary Paget's Disease.

Authors:  Uwe Wollina; Alberto Goldman; Andrzej Bieneck; Mohamed Badawy Abdel-Naser; Sven Petersen
Journal:  Curr Treat Options Oncol       Date:  2018-05-03

Review 2.  New Directions in Vulvar Cancer Pathology.

Authors:  Anthony Williams; Sheeba Syed; Shireen Velangi; Raji Ganesan
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 3.  Prognostic Factors of Extramammary Paget's Disease.

Authors:  Naohito Hatta
Journal:  Curr Treat Options Oncol       Date:  2018-08-15

4.  Treatment of Metastatic Primary Extramammary Paget Disease With Combination Anlotinib and Tislelizumab: A Case Report and Review of the Literature.

Authors:  Xin Yin; Xiaoqing Li; Muli Li; Qing She; Yan Liu; Xiaodan Chen; Suhua Ma; Qian Ma; Zhangkan Huang; Lin Xu; Xiaozhun Huang; Zhengyin Zhan; Xu Che
Journal:  Front Med (Lausanne)       Date:  2022-05-24

5.  Poorly Differentiated Scrotal Carcinoma With Apocrine Immunophenotype.

Authors:  Sonia Kamanda; Jonathan I Epstein; Adeboye O Osunkoya; Ashley Cimino-Mathews; Pedram Argani; Martin Sangüeza; Jose Antonio Plaza; Andres Matoso
Journal:  Am J Dermatopathol       Date:  2022-04-01       Impact factor: 1.533

Review 6.  Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

Authors:  Keitaro Fukuda; Takeru Funakoshi
Journal:  Front Oncol       Date:  2018-02-16       Impact factor: 6.244

7.  A case of extramammary inguinal Paget disease in a male patient: surgical treatment with an abdominal advancement cutaneous flap.

Authors:  Andrea Sisti; Juri Tassinari; Roberto Cuomo; Luca Milonia; Giuseppe Nisi; Cesare Brandi; Carlo D'Aniello; Luca Grimaldi
Journal:  Acta Biomed       Date:  2017-04-28

8.  Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.

Authors:  Zoran Gatalica; Semir Vranic; Božo Krušlin; Kelsey Poorman; Phillip Stafford; Denisa Kacerovska; Wijendra Senarathne; Elena Florento; Elma Contreras; Alexandra Leary; April Choi; Gino K In
Journal:  Cancer Med       Date:  2020-01-03       Impact factor: 4.452

Review 9.  Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review.

Authors:  Fulvio Borella; Mario Preti; Luca Bertero; Giammarco Collemi; Isabella Castellano; Paola Cassoni; Stefano Cosma; Andrea Roberto Carosso; Federica Bevilacqua; Niccolò Gallio; Chiara Benedetto; Leonardo Micheletti
Journal:  Int J Mol Sci       Date:  2020-12-27       Impact factor: 5.923

10.  MiR-155, a potential serum marker of extramammary Paget's disease.

Authors:  Hao Guo; Rui-Qun Qi; Jie Sheng; Chang Liu; Hang Ma; He-Xiao Wang; Jiu-Hong Li; Xing-Hua Gao; Yin-Sheng Wan; Hong-Duo Chen
Journal:  BMC Cancer       Date:  2018-11-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.